Novel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs.
Jiang N, Lin JJ, Wang J, Zhang BN, Li A, Chen ZY, Guo S, Li BB, Duan YZ, Yan RY, Yan HF, Fu XY, Zhou JL, Yang HM, Cui Y.
Jiang N, et al. Among authors: zhou jl.
Exp Ther Med. 2018 Sep;16(3):2183-2192. doi: 10.3892/etm.2018.6459. Epub 2018 Jul 17.
Exp Ther Med. 2018.
PMID: 30186457
Free PMC article.
Review.